Chu De Quebec-universite Laval

This study tests whether adding three cholesterol-lowering drugs (atorvastatin, ezetimibe, and evolocumab) to standard chemotherapy can slow or stop advanced pancreatic cancer. It involves 3 newly diagnosed adults with inoperable or metastatic pancreatic cancer. The goal is to se…

This study compares a new, ultra-short radiation schedule (5 treatments) against the standard longer course for prostate cancer that has spread to lymph nodes. About 500 men will receive either the short or standard radiation, plus a brachytherapy boost and hormone therapy. The g…

This study looks at whether taking omega-3 (EPA) supplements can reduce inflammation and improve quality of life in men with high-risk prostate cancer who have their prostate removed. About 130 participants will take either fish oil capsules or placebo for six weeks before surger…

This study tests a lab-made skin substitute on a single patient with dystrophic epidermolysis bullosa, a rare disease that causes fragile, blistering skin. The graft is designed to cover chronic wounds that haven't healed with standard treatments. The goal is to see if the graft …

This study tests whether a daily high-dose omega-3 supplement (fish oil) can slow the rise of PSA levels in men whose prostate cancer has returned after initial treatment. About 40 men with a rising PSA but no visible spread will take either the supplement or a placebo for one ye…

This study tested a special PET scan (18F-DCFPyL) to see if it can find cancer spread that standard scans miss in men with castration-resistant prostate cancer starting enzalutamide. About 50 men with no or few signs of spread on regular scans took part. The goal was to see if th…

This study tests whether starting nutritional counseling early in pregnancy can improve blood sugar control in women at risk for gestational diabetes. 150 pregnant women will receive either standard care or a personalized diet plan with dietitian sessions, online resources, and a…

This study looks at whether taking marine omega-3 fatty acids (found in fish oil) and a drug called dutasteride can stop low-risk prostate cancer from progressing. The 120 participants are men with low-grade prostate cancer who are under active surveillance. Researchers will meas…

This study explores how diet, physical activity, and other lifestyle factors influence the risk of prostate cancer in over 2000 men. Researchers aim to identify biological markers that can predict which men are at higher risk. The goal is to use these markers to create personaliz…